Wandeler, Gilles; Keiser, Olivia; Mulenga, Lloyd; Hoffmann, Christopher J; Wood, Robin; Chaweza, Thom; Brennan, Alana; Prozesky, Hans; Garone, Daniela; Giddy, Janet; Chimbetete, Cleophas; Boulle, Andrew; Egger, Matthias; IeDEA Southern Africa Collaboration, (2012). Tenofovir in second-line ART in Zambia and South Africa: collaborative analysis of cohort studies. Journal of acquired immune deficiency syndromes JAIDS, 61(1), pp. 41-8. Philadelphia, Pa.: Lippincott Williams & Wilkins 10.1097/QAI.0b013e3182632540
Text
00126334-201209010-00006.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (462kB) |
||
|
Text
Wandeler JAIDS 2012_61_manuscript.pdf - Accepted Version Available under License Publisher holds Copyright. Download (940kB) | Preview |
Tenofovir (TDF) is increasingly used in second-line antiretroviral treatment (ART) in sub-Saharan Africa. We compared outcomes of second-line ART containing and not containing TDF in cohort studies from Zambia and the Republic of South Africa (RSA).
Item Type: |
Journal Article (Original Article) |
---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Infectiology 04 Faculty of Medicine > Pre-clinic Human Medicine > Institute of Social and Preventive Medicine (ISPM) |
UniBE Contributor: |
Wandeler, Gilles, Keiser, Olivia, Egger, Matthias |
Subjects: |
600 Technology > 610 Medicine & health |
ISSN: |
0894-9255 |
Publisher: |
Lippincott Williams & Wilkins |
Language: |
English |
Submitter: |
Factscience Import |
Date Deposited: |
04 Oct 2013 14:35 |
Last Modified: |
05 Dec 2022 14:11 |
Publisher DOI: |
10.1097/QAI.0b013e3182632540 |
PubMed ID: |
22743595 |
Web of Science ID: |
000308352000012 |
BORIS DOI: |
10.7892/boris.13956 |
URI: |
https://boris.unibe.ch/id/eprint/13956 (FactScience: 220676) |